Companion Animals

Dog Allergic Skin Disease Welfare

Atopic dermatitis is one of the most common and welfare-compromising conditions in dogs. New biological treatments are transforming quality of life for severely affected dogs.

Key Facts

Canine atopic dermatitis affects 10-15% of dogs causing chronic itching and skin inflammation
The condition causes significant welfare harm through constant pruritus affecting sleep and behavior
Dupilumab-equivalent biologics and Janus kinase inhibitors provide effective itch relief within days
Long-term environmental control and allergen identification reduce trigger load
Combination of biological treatment and allergen management produces best welfare outcomes

Welfare Considerations

Atopic dermatitis welfare has been transformed by new biological treatments that provide rapid, effective itch relief without the significant side effects of chronic steroid use. Dogs with severe atopy can now achieve excellent quality of life with treatments that target the underlying immune dysregulation rather than suppressing symptoms with broad immunosuppressants.

What You Can Do

Seek specialist dermatology referral for dogs with severe or poorly controlled atopic dermatitis
Discuss biological treatment options including oclacitinib and lokivetmab with your veterinarian
Implement allergen identification and avoidance alongside medication for best welfare outcomes
Support dermatology research advancing our understanding of canine atopic disease mechanisms